Literature DB >> 11042383

Dopamine-melanin protects against tyrosine nitration, tryptophan oxidation and Ca(2+)-ATPase inactivation induced by peroxynitrite.

K Stepień1, A Zajdel, A Wilczok, T Wilczok, A Grzelak, A Mateja, M Soszyński, G Bartosz.   

Abstract

The effects of dopamine-melanin (DA-melanin), a synthetic model of neuromelanin, on peroxynitrite-mediated 3-nitrotyrosine formation, oxidation of tryptophan in bovine serum albumin and inactivation of erythrocyte membrane Ca(2+)-ATPase activity were investigated in the absence and in the presence of bicarbonate. DA-melanin inhibited nitration of free tyrosine, loss of tryptophan residues and Ca(2+)-ATPase inactivation by peroxynitrite in a dose dependent manner. In the presence of bicarbonate, this inhibitory effect was lower for nitration and insignificant for oxidative protein modifications. These results suggest that neuromelanin can protect against nitrating and oxidizing action of peroxynitrite but is a worse protector against the peroxynitrite-CO(2) adduct. As peroxynitrite may be a mediator of neurotoxic processes, the obtained results suggest that neuromelanin may be important as a physiological protector against peroxynitrite.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042383     DOI: 10.1016/s0304-4165(00)00121-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Protective effect of 1-methylated beta-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells.

Authors:  Won Tae Choi; Young Chul Youn; Eun Sook Han; Chung Soo Lee
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

2.  Inhibition of SIN-1-induced change in mitochondrial membrane permeability in PC12 cells by dopamine.

Authors:  Chung Soo Lee; Eun Sook Han; Jin Ho Song; Kyung Yong Kim
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

Review 3.  New hope for Parkinson's disease treatment: Targeting gut microbiota.

Authors:  Hong-Xia Fan; Shuo Sheng; Feng Zhang
Journal:  CNS Neurosci Ther       Date:  2022-07-13       Impact factor: 7.035

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.